XELLIA PHARMACEUTICALS 401(K) PLAN
ERISA Form 5500 plan record drawn from DOL EBSA — verify with linked source filings below.
XELLIA PHARMACEUTICALS USA LLC
This 401(k) plan holds $19M in total assets and serves 375 participants as of 2024. It is sponsored by XELLIA PHARMACEUTICALS USA LLC in Illinois. The plan reported a net loss of $3M for the year.
What the Filing Says About XELLIA PHARMACEUTICALS 401(K) PLAN
XELLIA PHARMACEUTICALS 401(K) PLAN is a 401(k) retirement plan sponsored by XELLIA PHARMACEUTICALS USA LLC, headquartered in Illinois. As of the 2024 Form 5500 filing, the plan reports $19M in total end-of-year assets and covers 375 participants across the Manufacturing industry. The sponsor's EIN on file with the U.S. Department of Labor is 471150410, and the plan has been effective since 2012-01-01. Its filing status is currently FILING RECEIVED.
Year over year, total assets moved from $23M at the beginning of 2024 to $19M at year-end — a decline of 15.3%. Net assets (after liabilities) closed the year at $19M, with reported net income of $-3,452,531 driven by investment returns, contributions received, and benefit payments during the period. These figures reflect what the plan administrator certified on Schedule H or Schedule I of the Form 5500 annual return and can be compared against 2 prior plan-year filings from the same sponsor shown below.
Asset totals and participant counts reflect a single plan year snapshot and can change materially with market conditions, plan mergers, or workforce changes. Fields such as "net income" include both realized investment performance and contribution/distribution flows — a single-year figure does not by itself indicate plan health or participant outcomes. This page summarizes public DOL disclosures for research and educational purposes only and is not retirement, tax, legal, or financial advice. Before making decisions about your own retirement benefits or evaluating an employer's plan, verify the underlying filing directly via the DOL EFAST2 system and consult a qualified professional.
Financial Summary (2023)
| Total Assets (Beginning of Year) | $23M |
| Total Assets (End of Year) | $19M |
| Net Assets (End of Year) | $19M |
| Net Income | $-3,452,531 |
| Plan Type | 401(k) |
| Employer EIN | 471150410 |
| Plan Effective Date | 2012-01-01 |
| Filing Status | FILING RECEIVED |
Sponsor Plan History (XELLIA PHARMACEUTICALS USA LLC)
| Year | Plans | Participants | Total Assets |
|---|---|---|---|
| 2022 | 1 | 304 | $17M |
| 2023 | 1 | 344 | $23M |
| 2024 | 1 | 375 | $19M |
Nearby 401(k) Plans in Illinois
Peer 401(k) plans — same state, same plan type — ranked by total assets.
- ACCENTURE UNITED STATES 401(K) MATCH SAVINGS PLAN $17.6B · 69,974
- STATE FARM 401(K) SAVINGS PLAN $16.9B · 60,246
- ABBOTT LABORATORIES STOCK RETIREMENT PLAN $14.5B · 38,012
- UNITED AIRLINES PILOT RETIREMENT ACCOUNT PLAN $14.4B · 14,959
- WALGREENS RETIREMENT SAVINGS PLAN $13.4B · 235,331
Related Data
Guides
Related Data on Other Portals
Frequently Asked Questions
How much money is in the XELLIA PHARMACEUTICALS 401(K) PLAN? ▼
What type of plan is XELLIA PHARMACEUTICALS 401(K) PLAN? ▼
Who sponsors the XELLIA PHARMACEUTICALS 401(K) PLAN? ▼
How did XELLIA PHARMACEUTICALS 401(K) PLAN perform in 2024? ▼
Where can I find official filings for XELLIA PHARMACEUTICALS 401(K) PLAN? ▼
How does XELLIA PHARMACEUTICALS 401(K) PLAN compare to other plans? ▼
Explore PlainRetire
Source: U.S. Department of Labor, Employee Benefits Security Administration (EBSA), Form 5500 public disclosure dataset. Plan year 2024.
Source: DOL EFAST2 filing system (efast.dol.gov) — original filing retrieval by EIN 471150410.
Reference: IRS Publication 560 — Retirement Plans for Small Business, contribution-limit rules.
Reference: IRS Publication 590-B — Distributions from IRAs, RMD rules under SECURE Act 2.0.
Read our methodology — how this data is sourced, computed, and verified.